Bio-Techne, Kantaro launch COVID-19 serology test

By The Science Advisory Board staff writers

August 3, 2020 -- Bio-Techne and Kantaro Biosciences have launched COVID-SeroIndex, a quantitative SARS-CoV-2 immunoglobulin G (IgG) antibody research-use only kit.

The companies will jointly commercialize and distribute the assay to support the SARS-CoV-2 vaccine development community. They anticipate the kits will be available in early August.

The enzyme-linked immunosorbent assay (ELISA) will measure the presence or absence of anti-COVID-19 antibodies and titer levels of antibodies. It will use two virus antigens: a full-length spike protein and a receptor-binding domain.

Kantaro Biosciences is the commercial arm of Mount Sinai Health System.


Copyright © 2020 scienceboard.net
 

Create an Account

Already have an account? Sign in Here

To access all ScienceBoard content create a free account now:



Email Address:  

First Name:

Last Name:

Learn about ScienceBoard

Get the latest life sciences research and industry news, delivered straight to your inbox, for free.

Why subscribe?

ScienceBoard is uniquely focused on the business of research, addressing the biggest problems that the biomedical industry face. You’ll get breaking news, events coverage, and deep dives into the science that drives innovation, delivered to your inbox daily.

 
I have read and agree to the privacy policy and terms of service and wish to opt-in for ScienceBoard.net.

Email Preferences



Letter from the Editor Please send me twice-weekly roundups of all the latest life research and industry news.
SAB Announcements Please send me the latest announcements from The Science Advisory Board and their partners.
Spotlight Receive notifications about new content, services, or educational resources designed to help you sharpen your skills and grow professionally.